Total assets increased 23.0%
Total assets changed +23.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$11.0B→$13.6B4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ZM financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital / assets moved 1669 bp lower
Working capital / assets changed -1669 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
60.81%→44.12%4 prior comparisons
Net income increased 330.1%
Net income changed +330.1% from the comparable as-filed period.
$358.6M→$1.5B2 prior comparisons
Working capital decreased 10.7%
Working capital changed -10.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$6.7B→$6.0B4 prior comparisons
Current liabilities increased 8.9%
Current liabilities changed +8.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$1.9B→$2.1B4 prior comparisons
Operating margin moved 182 bp lower
Operating margin changed -182 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
26.43%→24.61%2 prior comparisons
Current ratio decreased 14.0%
Current ratio changed -14.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
4.45→3.834 prior comparisons
Cash & equivalents decreased 22.2%
Cash & equivalents changed -22.2% from the comparable as-filed period.
$1.2B→$932.0M2 prior comparisons
Capital expenditure increased 180.6%
Capital expenditure changed +180.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$8.0M→$22.4M3 prior comparisons
Free-cash-flow proxy decreased 7.0%
Free-cash-flow proxy changed -7.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$508.0M→$472.4M3 prior comparisons
Free-cash-flow margin moved 475 bp lower
Free-cash-flow margin changed -475 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
41.73%→36.99%2 prior comparisons
Operating cash flow decreased 4.1%
Operating cash flow changed -4.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$515.9M→$494.8M3 prior comparisons
Operating cash flow / net income decreased 77.7%
Operating cash flow / net income changed -77.7% from the comparable as-filed period.
1.44→0.322 prior comparisons
Operating cash-flow margin moved 365 bp lower
Operating cash-flow margin changed -365 basis points from the comparable as-filed period.
42.39%→38.74%2 prior comparisons
Revenue increased 4.9%
Revenue changed +4.9% from the comparable as-filed period.
$1.2B→$1.3B2 prior comparisons
SBC / revenue moved 143 bp lower
SBC / revenue changed -143 basis points from the comparable as-filed period.
15.50%→14.08%2 prior comparisons
Research & development increased 17.5%
Research & development changed +17.5% from the comparable as-filed period.
$206.4M→$242.5M2 prior comparisons
Operating income decreased 2.3%
Operating income changed -2.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$321.7M→$314.3M2 prior comparisons
Gross margin moved 40 bp lower
Gross margin changed -40 basis points from the comparable as-filed period.
77.56%→77.16%2 prior comparisons
Current assets decreased 6.3%
Current assets changed -6.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$8.7B→$8.1B4 prior comparisons
Capex / revenue moved 110 bp higher
Capex / revenue changed +110 basis points from the comparable as-filed period.
0.65%→1.75%2 prior comparisons
R&D / revenue moved 203 bp higher
R&D / revenue changed +203 basis points from the comparable as-filed period.
16.96%→18.99%2 prior comparisons
Gross profit increased 4.4%
Gross profit changed +4.4% from the comparable as-filed period.
$944.1M→$985.5M2 prior comparisons
Receivables / revenue moved 73 bp lower
Receivables / revenue changed -73 basis points from the comparable as-filed period.
42.46%→41.73%2 prior comparisons
Stock-based compensation decreased 4.7%
Stock-based compensation changed -4.7% from the comparable as-filed period.
$188.7M→$179.8M2 prior comparisons
Trade receivables increased 3.1%
Trade receivables changed +3.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$516.8M→$533.0M4 prior comparisons
Capex / revenue moved 50 bp lower
Capex / revenue changed -50 basis points from the comparable as-filed period. The change ranks at the 40th percentile of 30 prior comparable changes.
2.21%→1.70%30 prior comparisons
Stock-based compensation decreased 11.2%
Stock-based compensation changed -11.2% from the comparable as-filed period. The change ranks at the 11th percentile of 54 prior comparable changes.
$201.6M→$179.0M54 prior comparisons
Revenue increased 5.5%
Revenue changed +5.5% from the comparable as-filed period. The change ranks at the 43th percentile of 54 prior comparable changes.
$1.2B→$1.2B54 prior comparisons
Operating cash flow increased 6.6%
Operating cash flow changed +6.6% from the comparable as-filed period. The change ranks at the 10th percentile of 30 prior comparable changes.
$489.3M→$521.6M30 prior comparisons
Gross profit increased 7.6%
Gross profit changed +7.6% from the comparable as-filed period. The change ranks at the 43th percentile of 54 prior comparable changes.
$896.3M→$964.7M54 prior comparisons
Gross margin moved 156 bp higher
Gross margin changed +156 basis points from the comparable as-filed period. The change ranks at the 56th percentile of 54 prior comparable changes.
76.30%→77.86%54 prior comparisons
Free-cash-flow proxy increased 8.0%
Free-cash-flow proxy changed +8.0% from the comparable as-filed period. The change ranks at the 13th percentile of 30 prior comparable changes.
$463.4M→$500.5M30 prior comparisons
Operating margin moved 449 bp higher
Operating margin changed +449 basis points from the comparable as-filed period. The change ranks at the 31th percentile of 54 prior comparable changes.
20.57%→25.06%54 prior comparisons
Operating income increased 28.5%
Operating income changed +28.5% from the comparable as-filed period. The change ranks at the 13th percentile of 54 prior comparable changes.
$241.6M→$310.5M54 prior comparisons
Capital expenditure decreased 18.5%
Capital expenditure changed -18.5% from the comparable as-filed period. The change ranks at the 27th percentile of 30 prior comparable changes.
$25.9M→$21.1M30 prior comparisons
Net income increased 67.2%
Net income changed +67.2% from the comparable as-filed period. The change ranks at the 20th percentile of 54 prior comparable changes.
$254.6M→$425.7M54 prior comparisons
Cash & equivalents decreased 27.5%
Cash & equivalents changed -27.5% from the comparable as-filed period. The change ranks at the 31th percentile of 96 prior comparable changes.
$1.2B→$890.9M96 prior comparisons
Research & development increased 11.0%
Research & development changed +11.0% from the comparable as-filed period. The change ranks at the 28th percentile of 54 prior comparable changes.
$205.4M→$227.9M54 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.